Clinical Trials Directory

Trials / Unknown

UnknownNCT02159430

Hereditary AngioEdema, Neurobiology and Psychopathology

Status
Unknown
Phase
Study type
Observational
Enrollment
35 (estimated)
Sponsor
University Hospital, Catania · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Since 1963 Hereditary AngioEdema (HAE) is considered an autosomal dominant disorder (Donaldson and Evans), characterized by a quantitative and/or qualitative deficit of C1 esterase inhibitor (C1-INH), which affects approximately 1:50.000 individuals in the general population. From this period the link between HAE and psychiatry was interrupted, however genetic issues could not comprehensively explain the clinical evolution of the disease. Clinical studies show an evident gap between genotype and phenotype of HAE. For this still controversial question, we have designed this cross-sectional study in order to establish the relationship between HAE clinical manifestations and neurobiological/psychopatological parameters.

Conditions

Interventions

TypeNameDescription
OTHERClinical and psychopathological assessment of HAE patients

Timeline

Start date
2014-11-01
Primary completion
2015-02-01
Completion
2015-05-01
First posted
2014-06-10
Last updated
2014-06-10

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02159430. Inclusion in this directory is not an endorsement.

Hereditary AngioEdema, Neurobiology and Psychopathology (NCT02159430) · Clinical Trials Directory